Patents by Inventor Yeon-Soo Kim

Yeon-Soo Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200009530
    Abstract: The super absorbent polymer comprises: a base polymer powder including a first crosslinked polymer of a water-soluble ethylenically unsaturated monomer having at least partially neutralized acidic groups; and a surface crosslinked layer formed on the base polymer powder and including a second crosslinked polymer in which the first crosslinked polymer is further crosslinked via a surface crosslinking agent, wherein the super absorbent polymer has: a fixed height absorption (FHA) of 22.5 g/g to 29 g/g, a saline flow conductivity (SFC) of 35(·10?7 cm3·s/g) or more, and T-20 of 180 seconds or less.
    Type: Application
    Filed: October 25, 2017
    Publication date: January 9, 2020
    Applicant: LG Chem, Ltd.
    Inventors: Tae Bin Ahn, Dong Hyun Kim, Yeon Soo Kim, Hyun Sup Lee, Chang Sun Han, Myung Han Lee
  • Publication number: 20190276609
    Abstract: The present invention relates to a superabsorbent polymer that not only has excellent basic absorption performance, but also exhibits more improved absorption speed, permeability, etc., and a method for preparing the same. The superabsorbent polymer includes a base polymer powder including: a first crosslinked polymer of water soluble ethylenically unsaturated monomers having acid groups of which at least a part are neutralized; and a surface crosslink layer that is formed on the base polymer powder, and further includes a second crosslinked polymer in which the first crosslinked polymer is additionally crosslinked by a C2-5 alkylene carbonate, wherein an absorption degree, SFC, an absorption speed, and a porosity fulfill specific ranges.
    Type: Application
    Filed: January 11, 2018
    Publication date: September 12, 2019
    Applicant: LG Chem, Ltd.
    Inventors: Hyemin Lee, Taebin Ahn, Hyunsup Lee, Yeon Soo Kim
  • Publication number: 20190106735
    Abstract: According to the present disclosure, a cancer gene analysis method comprises performing multiplex polymerase chain reaction (MPCR) on a nucleic acid sample extracted from a biological sample using a cancer gene-specific primer set including four or more species of sequences selected from the group consisting of sequence numbers 1 to 72, performing multiplex real-time polymerase chain reaction (MRTPCR) on a product of the MPCR using the primer set and a marker, and identifying the type of the cancer gene using a product of the MRTPCR. The primer set includes an oligonucleotide of a dumbbell structure represented in the following formula: 5?-Ap-Bq-Cr-3?.
    Type: Application
    Filed: May 16, 2018
    Publication date: April 11, 2019
    Inventors: Seong-Sik LIM, Yeon-Soo KIM, Jun KANG, Jung Suk LIM, Se Eun PARK
  • Patent number: 10228501
    Abstract: The present invention relates to a method for manufacturing a polarizer, including: a) immersing and swelling a polyvinyl alcohol-based film in an aqueous solution containing an azo-based dye having an absorption wavelength of 300 nm to 550 nm; b) dyeing the swollen polyvinyl alcohol-based film with an iodine-based dye; and c) stretching the dyed polyvinyl alcohol-based film, and a polarizer manufactured using the method.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: March 12, 2019
    Assignee: LG CHEM, LTD.
    Inventors: Jae Il Ryu, Eung Jin Jang, Jin Yong Park, Eungki Lee, Hyung Koo Kang, Taek Geun Nam, Deok Woo Park, Young Gon Kim, Yeon Soo Kim, You Kyeong Kim
  • Publication number: 20180362986
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer containing pleiotropic regulator 1 (PLRG1) inhibitor as an active ingredient, a method for treating cancer including administering the composition to a subject, a composition for diagnosing cancer containing an agent for measuring the expression level of PLRG1, a method for providing information for diagnosing cancer including measuring the expression level of PLRG1, and a method for screening agents for preventing or treating cancer. Pleiotropic regulator 1 (PLRG1) is overexpressed in cancer cells, and the inhibition of the expression of PLRG1 can induce cancer cell-specific apoptosis. Accordingly, the PLRG1 inhibitor of the present invention has an excellent effect as an anticancer agent without side effects, and additionally, the PLRG1 inhibitor can be used for cancer diagnosis, screening of anticancer agents, etc. by measuring the expression levels of PLRG1.
    Type: Application
    Filed: October 7, 2016
    Publication date: December 20, 2018
    Inventors: Kee-Ho LEE, Sungsub KIM, Yeon-Soo KIM, Eun-Ran PARK, Hyun Jin SHIN, Eun-Ju LEE, Yong-Ho HAM, Sang Bum KIM, Sun-Hoo PARK, Chul-Ju HAN, Sung Hee HONG, Yang Hyun KIM, Jung Min KIM, Mi Yeun KIM, Moonkyoung KANG, Eun Yeong SONG, Jie Young SONG
  • Patent number: 10039841
    Abstract: The present invention relates to a replication retrovirus vector system comprising thymidine kinase (HSV-TK) gene and cytosine deaminase (CD) gene which make gene transfer to cancer cell tissue for the efficient treatment of cancer. Particularly, the HSV-TK/CD combined self-replicating retrovirus vector system of the present invention characteristically contains both HSV-TK and CD genes; has no worries about losing a therapeutic gene because recombination does not occur in this system during virus infection; and has an excellent stability, and also is able to induce cancer cell death by using the prodrug GCV or 5-FC and can apply a therapeutic gene or a prodrug thereof selectively to such cancer that shows resistance against cancer treatment using either TK or CD, so that this system of the invention can be advantageously used as a pharmaceutical composition for the treatment of cancer.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: August 7, 2018
    Assignee: THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: Yeon Soo Kim, Moonkyung Kang, Min Jeong Baek
  • Patent number: 10011743
    Abstract: A dielectric adhesive film for an electronic paper display device, by which the operating performance of a flexible display device is excellent even applying a high voltage when the flexible display device is operated, by controlling a dielectric constant with respect to an adhesive film for attaching a lower electrode to which a voltage is applied with an image upper electrode on which particles, which possess electric charges with various colors that change according to an applied voltage, are coated to adjust the electric charges of the adhesive film in the thickness direction to thereby minimize loss of the applied voltage while maintaining an adhesive property and reliability.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: July 3, 2018
    Assignee: TORAY ADVANCED MATERIALS KOREA, INC.
    Inventors: Dong Han Kho, Sang Hoon Lee, Chang Ik Hwang, Yeon Soo Kim
  • Publication number: 20180147299
    Abstract: The present invention relates to a replication retrovirus vector system comprising thymidine kinase (HSV-TK) gene and cytosine deaminase (CD) gene which make gene transfer to cancer cell tissue for the efficient treatment of cancer. Particularly, the HSV-TK/CD combined self-replicating retrovirus vector system of the present invention characteristically contains both HSV-TK and CD genes; has no worries about losing a therapeutic gene because recombination does not occur in this system during virus infection; and has an excellent stability, and also is able to induce cancer cell death by using the prodrug GCV or 5-FC and can apply a therapeutic gene or a prodrug thereof selectively to such cancer that shows resistance against cancer treatment using either TK or CD, so that this system of the invention can be advantageously used as a pharmaceutical composition for the treatment of cancer.
    Type: Application
    Filed: November 30, 2016
    Publication date: May 31, 2018
    Applicant: The Industry & Academic Cooperation in Chungnam National University (IAC)
    Inventors: Yeon Soo KIM, Moonkyung KANG, Min Jeong BAEK
  • Publication number: 20180073082
    Abstract: The present invention relates to a dumbbell-structure oligonucleotide (DSO), a nucleic acid amplification primer comprising the same, and a nucleic acid amplification method using the same and, more specifically, to a method for multi-gene amplification and single-nucleotide polymorphism analysis using a dumbbell-structure oligonucleotide capable of excluding non-specific amplification products prior to binding to a template in a first cycle in performing a polymerase chain reaction.
    Type: Application
    Filed: February 25, 2015
    Publication date: March 15, 2018
    Inventors: Seong-Sik LIM, Yeon-Soo KIM
  • Publication number: 20170285236
    Abstract: The present invention relates to a method for manufacturing a polarizer, including: a) immersing and swelling a polyvinyl alcohol-based film in an aqueous solution containing an azo-based dye having an absorption wavelength of 300 nm to 550 nm; b) dyeing the swollen polyvinyl alcohol-based film with an iodine-based dye; and c) stretching the dyed polyvinyl alcohol-based film, and a polarizer manufactured using the method.
    Type: Application
    Filed: September 21, 2015
    Publication date: October 5, 2017
    Inventors: Jae Il RYU, Eung Jin JANG, Jin Yong PARK, Eungki LEE, Hyung Koo KANG, Taek Geun NAM, Deok Woo PARK, Young Gon KIM, Yeon Soo KIM, You Kyeong KIM
  • Patent number: 9657312
    Abstract: The present invention provides a vector system in which a MuLV-Gag gene, a MuLV-Pol gene, and a GaLV-Env gene are expressed in two separate vectors. The vector system is capable of inserting a therapeutic gene to these two separate vectors, and in this raged, the size of an inserted gene is not limited and a variety of foreign therapeutic genes may be inserted to the vectors. Accordingly, the foreign therapeutic gene may be delivered in a safe and efficient manner to desired tissue of cells of aberrant proliferation. Therefore, the vector system is applicable in a composition for delivering a gene targeting the aberrantly dividing cells of aberrant proliferation, wherein the composition includes a retrovirus produced by cell line transfection. The vector system is also applicable in a composition for preventing or treating a disease caused by cells of aberrant proliferation of, such as cancer cells.
    Type: Grant
    Filed: March 13, 2012
    Date of Patent: May 23, 2017
    Assignee: Inje University Industry-Academic Cooperation Foundation
    Inventors: Yeon Soo Kim, Moon Kyung Kang, A Young Song
  • Patent number: 9560087
    Abstract: The disclosure is related to providing a machine to machine (M2M0 service. A user interface (UI) template associated with a M2M device may be retrieved when a message is received from the M2M device. Then, data collected from the M2M device may be combined with the retrieved UI template. The M2M service associated with the M2M device may be provided by embedding the combined data to application data for producing a M2M service user interface (UI) of the associated M2M service.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: January 31, 2017
    Assignee: KT CORPORATION
    Inventors: Su-Jin Kang, Sung-Phil Heo, Sang-Eon Kim, Yeon-Soo Kim, Han-Wook Jung
  • Publication number: 20150176026
    Abstract: The present invention provides a vector system in which a MuLV-Gag gene, a MuLV-Pol gene, and a GaLV-Env gene are expressed in two separate vectors. The vector system is capable of inserting a therapeutic gene to these two separate vectors, and in this raged, the size of an inserted gene is not limited and a variety of foreign therapeutic genes may be inserted to the vectors. Accordingly, the foreign therapeutic gene may be delivered in a safe and efficient manner to desired tissue of cells of aberrant proliferation. Therefore, the vector system is applicable in a composition for delivering a gene targeting the aberrantly dividing cells of aberrant proliferation, wherein the composition includes a retrovirus produced by cell line transfection. The vector system is also applicable in a composition for preventing or treating a disease caused by cells of aberrant proliferation of, such as cancer cells.
    Type: Application
    Filed: March 13, 2012
    Publication date: June 25, 2015
    Applicant: INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Yeon Soo Kim, Moon Kyung Kang, A Young Song
  • Publication number: 20150118432
    Abstract: The present disclosure provides a dielectric adhesive film for an electronic paper display device, by which the operating performance of a flexible display device is excellent even applying a high voltage when the flexible display device is operated, by controlling a dielectric constant with respect to an adhesive film for attaching a lower electrode to which a voltage is applied with an image upper electrode on which particles, which possess electric charges with various colors that change according to an applied voltage, are coated to adjust the electric charges of the adhesive film in the thickness direction to thereby minimize loss of the applied voltage while maintaining an adhesive property and reliability.
    Type: Application
    Filed: May 21, 2012
    Publication date: April 30, 2015
    Inventors: Dong Han Kho, Sang Hoon Lee, Chang Ik Hwang, Yeon Soo Kim
  • Patent number: 8986832
    Abstract: Disclosed is an optical-modulation object, including birefringent island-in-the-sea yarns, whose island portions are grouped, based on two or more spinning cores, in a matrix. The optical-modulation object causes formation of an optical modulation interface between island portions and sea portions, thus maximizing optical modulation efficiency, as compared to conventional birefringent island-in-the-sea yarns.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: March 24, 2015
    Assignee: Woongjin Chemical Co., Ltd.
    Inventors: Yeon Soo Kim, Deog Jae Jo, Jin Soo Kim, Do Hyun Kim, In Young Yang
  • Publication number: 20130171399
    Abstract: A dielectric adhesive film for an electronic paper display device. A lower electrode to which voltage is applied and an image upper electrode coated with charged particles whose colors are changed depending on the applied voltage are attached to the adhesive film. Thickness of the adhesive film is controlled to be uniform and constant, and a resistance value in the thickness direction of the adhesive film, i.e., a resistance value in the direction where an electric field is formed, is controlled without changing adhesive properties and reliability as the thickness of the adhesive film is controlled. Since loss of the applied voltage is minimized and the charged particles are freely driven, driving performance of the display device is excellent although a high voltage is not applied in driving a flexible display device, such as a flexible LED, an organic electro luminescence (EL) element including an electronic paper, and the like.
    Type: Application
    Filed: October 19, 2011
    Publication date: July 4, 2013
    Applicant: Toray Advanced Materials Korea Inc.
    Inventors: Dong Han Kho, Sang Hoon Lee, Chang Ik Hwang, Yeon Soo Kim
  • Patent number: 8395481
    Abstract: The present invention relates to an RFID reader and a method thereof, and an RFID data processing method. The RFID reader generates a specific query message to a plurality of RFIDs, receives a first response message corresponding to the query message from at least one RFID among the RFIDs, and sequentially identifies a tag ID of a collided RFID by using a collision solving message when a collision occurs according to the result of receiving a first response message. The RFID reader can quickly and accurately identify a plurality of RFIDs since it can eliminate an unnecessary time such as excessive no response slot generation or repeated rounds through a sequential identification process for the collided RFIDs.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: March 12, 2013
    Assignee: KT Corporation
    Inventor: Yeon-Soo Kim
  • Patent number: 8325665
    Abstract: A method for selecting an operational channel of a wireless narrow area network, a coordinator using the same, and a computer-readable recording media recording a program for realizing the method. More particularly, a method for selecting an operational channel of a wireless narrow area network in which one radio channel is occupied by a plurality of coordinators at different timings by selecting a predetermined period of a radio channel where a coordinator of the wireless narrow area network is used by another coordinator as own operational channel, a coordinator using the same, and a computer-readable recording media recording a program for realizing the method.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: December 4, 2012
    Assignee: KT Corporation
    Inventors: Yeon-Soo Kim, Hak-Jin Chong, Youn-Suk Koh, Chae-Eun Hwang, legal representative
  • Publication number: 20120293626
    Abstract: Disclosed herein is a 3D distance measurement system. The 3D distance measurement system includes an image projection device for projecting a pattern image including one or more patterns on a target object, and an image acquisition device for acquiring a projected pattern image, analyzing the projected pattern image using the patterns, and then reconstructing a 3D image. Each of the patterns includes one or more preset identification factors so that the patterns can be uniquely recognized, and each of the identification factors is one of a point, a line, and a surface, or a combination of two or more of a point, a line, and a surface. The 3D distance measurement system is advantageous in that it reconstructs a 3D image using a single pattern image, thus greatly improving processing speed and the utilization of a storage space and enabling a 3D image to be accurately reconstructed.
    Type: Application
    Filed: May 17, 2012
    Publication date: November 22, 2012
    Applicant: IN-G Co., Ltd.
    Inventors: Suk-Han LEE, Dae-Sik KIM, Yeon-Soo KIM
  • Patent number: 8313744
    Abstract: The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence seizure specific SWD was reduced by administrating PKC agonist into an animal model. Therefore, the composition of the present invention comprising PKC agonist as an active ingredient can be effectively used for the prevention and treatment of absence seizure and for the production of health improving functional food.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 20, 2012
    Assignee: Korea Institute of Science and Technology
    Inventors: Eunji Cheong, Hee-Sup Shin, Yihong Zheng, Kyoobin Lee, Jungryun Lee, Seongwook Kim, Maryam Sanati, Sukyung Lee, Yeon-Soo Kim, Sukchan Lee